Search Results - E. A. Orlova

Optimization of pharmacotherapy of COPD patients using EURO FORTA and STOPP/START criteria by E. A. Orlova

Connect to this object online.

Patient with comorbid pathology: is ASIT possible? by E. A. Orlova, Yu. A. Kandrashkina, E. Yu. Trushina, E. M. Kostina

Connect to this object online.

PHARMACOECONOMIC EVALUATION OF ANTI-PNEUMOCOCCAL VACCINATION IN RISK GROUPS FOR THE PREVENTION OF COMMUNITY-ACQUIRED PNEUMONIA AMONG ADULTS IN THE ASTRAKHAN REGION by E. A. Orlova, I. P. Dorfman, M. A. Orlov, M. A. Abdullaev

Connect to this object online.

Experience of allergen-specific immunotherapy in the patient with oral and systemic manifestations of birch pollen allergy by E. Y. Trushina, E. M. Kostina, E. A. Orlova, A. A. Turovskaya, T. A. Nefedova

Connect to this object online.

Analysis of the availability of bronchodilators and anti-inflammatory drugs for patients with chronic obstructive pulmonary disease by E. A. Orlova, V. I. Petrov, I. P. Dorfman, O. V. Shatalova, M. A. Orlov

Connect to this object online.

ЕSTIMATION OF SOCIO-ECONOMIC BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE FOR A 5-YEAR PERIOD: A REGIONAL ASPECT by E. A. Orlova, A. R. Umerova, I. P. Dorfman, M. A. Orlov, M. A. Abdullaev

Connect to this object online.

PHARMACOGENETIC BASES OF INDIVIDUAL SENSITIVITY AND PERSONALIZED ADMINISTRATION OF ANTIPLATELET THERAPY IN DIFFERENT ETHNIC GROUPS by B. I. Kantemirova, E. A. Orlova, O. S. Polunina, E. N. Chernysheva, M. A. Abdullaev, D. A. Sychev

Connect to this object online.

ECONOMIC DAMAGE OF PNEUMOCOCCAL VACCINATION ABSENCE AS A RISK FACTOR FOR COMPLICATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE by E. A. Orlova, I. P. Dorfman, A. R. Umerova, B. I. Kantemirova, M. A. Orlov, M. A. Abdullaev

Connect to this object online.